- Filed
- Oct 22, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Oct 22, 2024 | 551.5K sh |
| Cash And Equivalents | Q3 2024 · Jun 30, 2024 | $428.39K |
| Cash And Equivalents | Q3 2024 · Sep 30, 2023 | $82.74K |
| Current Liabilities | Q3 2024 · Jun 30, 2024 | $5.03M |
| Current Liabilities | Q3 2024 · Sep 30, 2023 | $3.43M |
| Total Liabilities | Q3 2024 · Jun 30, 2024 | $5.35M |
| Total Liabilities | Q3 2024 · Sep 30, 2023 | $3.77M |
| Current Assets | Q3 2024 · Jun 30, 2024 | $549.9K |
| Current Assets | Q3 2024 · Sep 30, 2023 | $288.42K |
| Total Assets | Q3 2024 · Jun 30, 2024 | $11.03M |
| Total Assets | Q3 2024 · Sep 30, 2023 | $10.94M |
| Shares Diluted restated | Q3 2024 · Jun 30, 2023 | 491.04K sh |
| Shares Diluted restated | Q3 2024 · Jun 30, 2023 | 485.78K sh |
| Capex | Q3 2024 · Jun 30, 2023 | $1.25M |
| Operating Cash Flow | Q3 2024 · Jun 30, 2023 | −$1.94M |
| Stockholders Equity | Q3 2024 · Jun 30, 2023 | $7.82M |
| Stockholders Equity | Q3 2024 · Mar 31, 2023 | $8.04M |
| Stockholders Equity | Q3 2024 · Sep 30, 2022 | $10.46M |
| Eps Diluted restated | Q3 2024 · Jun 30, 2023 | −$2.96 |
| Eps Diluted restated | Q3 2024 · Jun 30, 2023 | −$7.97 |
| Eps Basic restated | Q3 2024 · Jun 30, 2023 | −$2.96 |
| Eps Basic restated | Q3 2024 · Jun 30, 2023 | −$7.97 |
| Sga Expense | Q3 2024 · Jun 30, 2023 | $788.66K |
| Sga Expense | Q3 2024 · Jun 30, 2023 | $3.01M |
| Net Income | Q3 2024 · Jun 30, 2023 | −$909.59K |
| Net Income | Q3 2024 · Jun 30, 2023 | −$3.33M |
| Operating Income restated | Q3 2024 · Jun 30, 2023 | −$912.43K |
| Operating Income restated | Q3 2024 · Jun 30, 2023 | −$3.36M |
| Revenue | Q3 2024 · Jun 30, 2023 | $156.72K |
| Revenue | Q3 2024 · Jun 30, 2023 | $541.46K |